Skip to content

Evaluation of the "Hot Spaxus" Lumen Apposing Stent for EUS-guided drainage of pancreatic walled off necrosis

Multicentre, Prospective Evaluation of the "Hot Spaxus" Lumen Apposing Stent for EUS-Guided Drainage of Pancreatic Walled Off Necrosis in Adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000140853
Acronym
None
Enrollment
1
Registered
2021-02-11
Start date
2020-12-09
Completion date
2023-02-01
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Acute pancreatitis can be complicated by local fluid collections in approximately 40% of cases. Sometimes these fluid collections contain necrotic debris (dead tissue), and are called walled off necrosis (WON). This can result in infection, pain, fevers or gastrointestinal upset. It can be life threatening without appropriate medical therapy. The primary treatment of pancreatic walled off necrosis is drainage of this collection into the stomach or duodenum (first part of the small bowel) using a stent inserted under endoscopic ultrasound (EUS) guidance. This study is being performed to assess the safety and effectiveness of a recently available TGA approved stent called the Hot SPAXUS stent. The Hot SPAXUS stent has been used for drainage of pancreatic fluid collections in the United States of America, Korea and parts of Europe. This research project is investigating its role in managing pancreatic WON collections in Australia, to provide further information on its use.

Interventions

Endoscopic ultrasound guided insertion of a fully covered lumen apposing stent (Hot SPAXUS) to drain symptomatic walled off necrosis. This intervention takes approximately 15 minutes. The administeration of the intervention will be performed by an expert interventional gastroenterologist in an endoscopy room or theatre room. The patient will be followed up at a minimum to assess clinical progress at 4 weeks and 3 months.

Sponsors

St Vincent's Hospital Melbourne
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged 18 years old and over, and 2. Medically fit for anaesthesia, and 3. Pancreatic or peri-pancreatic walled off necrosis that is either symptomatic or infected, and 4. Imaging evidence of a WON on MRI or CT, and 5. Informed consent obtained from the patient or legal representative

Exclusion criteria

1. Aged under 18 years old 2. Pregnant at enrolment 3. Unable to obtain informed consent from the patient or legal representative 4. Medically unfit for anaesthesia 5. Asymptomatic collection 6. Irreversible coagulopathy: INR > 1.5 7. Irreversible thrombocytopenia: platelet count <50 x 109/L 8. Dual antiplatelet therapy or therapeutic anticoagulation that cannot be withheld for the procedure 9. WON secondary to trauma or other surgical event that requires additional interventions such as management of liver lacerations or vascular injury 10. Surgical or endoscopic necrosectomy or pseudocyst drainage that has been performed within the preceding 12 months 11. On EUS, located >10mm from GI lumen, immature wall, intervening vessel or structure, WON size <3cm, WON contains >80% solid necrosis

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026